Head & neck cancers

Amivantamab Demonstrates Promising Activity in Heavily Pretreated Disease

Barbara Burtness, MD, Paul Swiecicki, MD, Ari Rosenberg, MD, Jessica Geiger, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Defining the Current Landscape in Recurrent Metastatic Head and Neck Cancer

Barbara Burtness, MD, Paul Swiecicki, MD, Ari Rosenberg, MD, Jessica Geiger, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Clinical Insights: Role of Amivantamab in Head and Neck Cancer

Barbara Burtness, MD, Ari Rosenberg, MD, Jessica Geiger, MD, Paul Swiecicki, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD